Answers are grounded in this paper and cite their sources.
Several preparations of a derivative of amylopectin (hydroxyethyl starch) have been shown not to be immunogenic in rabbits, guinea pigs and man. It appears from these studies that HES merits further investigation as a possible plasma expander provided it has no deleterious effects on soluble or cellular components of blood.
No takes yet. Share an insight, caveat, or question.
Maurer et al. (1968) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: